In the 2017 financial year, sales showed positive growth in every region. Thanks to the successful integration of Tegra Medical, the share of sales generated in the Americas rose 39.9% and amounted to CHF 281.4 million. This acquisition has altered the regional sales mix and raised the sales contribution from the Americas region to 17.2%. Significant progress towards the targeted diversification was thus made during the year under review.

In Asia, too, year-on-year sales growth was a high 16.6%, bringing full-year sales from this region to CHF 353.9 million. Growth here is primarily attributed to the Electronics division. Business trends at the other units active in Asia were also very positive.

SFS Group AG published this content on 26 January 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 26 January 2018 05:44:05 UTC.

Original documenthttps://www.sfs.biz/en/web/medien/medienmitteilungen/news_detail_35935040.html

Public permalinkhttp://www.publicnow.com/view/9A30C155103FC9B66F85D1B77031AF2C2B2941C7